This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Article 1 of the Pharmaceutical Law of 19/12/2014, Journal of Laws of the Republic of Poland 2015, 0, item 28, as amended.Article 1 of the Pharmaceutical Law of 19/12/2014Journal of Laws of the Republic of Poland20150, item 28, as amendedSearch in Google Scholar
Article 118 of the Pharmaceutical Law of 06/09/2001, Journal of Laws of the Republic of Poland 2001, 126, item 1381, as amended.Article 118 of the Pharmaceutical Law of 06/09/2001Journal of Laws of the Republic of Poland2001126, item 1381, as amendedSearch in Google Scholar
Article 2 point 9 of the Pharmaceutical Law of 06/09/2001, Journal of Laws of the Republic of Poland 2001, 126, item 1381, as amended.Article 2 point 9 of the Pharmaceutical Law of 06/09/2001Journal of Laws of the Republic of Poland2001126, item 1381, as amendedSearch in Google Scholar
Article 81 of Directive 2001/82/EC, as amended by Directive 2004/28/EC, of the European Parliament and the Council.Article 81 of Directive2001/82/ECas amended by Directive 2004/28/EC, of the European Parliament and the CouncilSearch in Google Scholar
Article 82 of Directive 2001/82/EC, as amended by Directive 2004/28/EC, of the European Parliament and the Council.Article 82 of Directive2001/82/ECas amended by Directive 2004/28/EC, of the European Parliament and the CouncilSearch in Google Scholar
Chang Y., Brewer N.T., Rinas A.C., Schmitt K., Smith J.S.: Evaluating the impact of human papillomavirus vaccines. Vaccine 2009, 27, 4355–4362. doi:10.1016/j.vaccine.2009.03 .008. PMID 19515467.ChangY.BrewerN.T.RinasA.C.SchmittK.SmithJ.S.Evaluating the impact of human papillomavirus vaccinesVaccine20092743554362doi10.1016/j.vaccine.2009.03.008PMID 1951546719515467Open DOISearch in Google Scholar
Council of Europe: Presentation of the EDQM and its activities. 2016. https://www.youtube.com/watch?v=YWN7BsUyipcCouncil of Europe: Presentation of the EDQM and its activities2016https://www.youtube.com/watch?v=YWN7BsUyipcSearch in Google Scholar
Encyclopedia Britannica: Entry on vaccines. https://www.britannica.com/science/vaccineEncyclopedia Britannica: Entry on vaccineshttps://www.britannica.com/science/vaccineSearch in Google Scholar
EudraVigilance – European database of reports on suspected adverse drug reactions: Medicines in the EU. http://www.adrreports.eu/en/medicines_in_EU.htmlEudraVigilance – European database of reports on suspected adverse drug reactions: Medicines in the EUhttp://www.adrreports.eu/en/medicines_in_EU.htmlSearch in Google Scholar
European Directorate for the Quality of Medicines & HealthCare (EDQM): Institutional Brochure. https://www.edqm.eu/sites/default/files/institutional-brochure-edqm.pdfEuropean Directorate for the Quality of Medicines & HealthCare (EDQM): Institutional Brochurehttps://www.edqm.eu/sites/default/files/institutional-brochure-edqm.pdfSearch in Google Scholar
European Directorate for the Quality of Medicines & HealthCare (EDQM): Levels of collaboration within the General European OMCL Network (GEON). https://www.edqm.eu/en/Levels-of-Collaboration-within-the-OMCL-129.htmlEuropean Directorate for the Quality of Medicines & HealthCare (EDQM): Levels of collaboration within the General European OMCL Network (GEON)https://www.edqm.eu/en/Levels-of-Collaboration-within-the-OMCL-129.htmlSearch in Google Scholar
European Directorate for the Quality of Medicines & HealthCare (EDQM): Official website. https://www.edqm.eu/European Directorate for the Quality of Medicines & HealthCare (EDQM): Official websitehttps://www.edqm.eu/Search in Google Scholar
European Medicines Agency: Official website. https://www.ema.europa.eu/European Medicines Agency: Official websitehttps://www.ema.europa.eu/Search in Google Scholar
European Union: Website listing EU agencies. https://europa.eu/european-union/about-eu/agencies/ema_plEuropean Union: Website listing EU agencieshttps://europa.eu/european-union/about-eu/agencies/ema_plSearch in Google Scholar
Fijałek Z.: Role of the National Medicines Institute in quality assurances and safety of medicinal products and medical devices. Przegl Med Uniw Rzeszowskiego i Narod Inst Lek w Warszawie 2010, 3, 259–270.FijałekZ.Role of the National Medicines Institute in quality assurances and safety of medicinal products and medical devicesPrzegl Med Uniw Rzeszowskiego i Narod Inst Lek w Warszawie20103259270Search in Google Scholar
Fiore A.E., Bridges C.B., Cox N.J.: Seasonal influenza vaccines. Current Topics Microbiol Immunol 2009, 333, 43–82. doi:10.1007/978-3-540-92165-3_3. ISBN 978-3-540-92164-6. PMID 19768400.FioreA.E.BridgesC.B.CoxN.J.Seasonal influenza vaccinesCurrent Topics Microbiol Immunol20093334382doi10.1007/978-3-540-92165-3_3ISBN 978-3-540-92164-6. PMID 1976840019768400Open DOISearch in Google Scholar
Guo Y., Lei K., Tang L.: Neoantigen vaccine delivery for personalized anticancer immunotherapy. Front Immunol 2018, 9, 1–8. doi: 10.3389/fimmu.2018.01499. eCollection 2018.GuoY.LeiK.TangL.Neoantigen vaccine delivery for personalized anticancer immunotherapyFront Immunol2018918doi10.3389/fimmu.2018.01499eCollection 2018603611430013560Open DOISearch in Google Scholar
Kretzschmar E., Muckenfuss H., Pfleiderer M.: Official batch control of influenza vaccines: Is it still useful? Vaccine 2018, 36, 2364–2370.KretzschmarE.MuckenfussH.PfleidererM.Official batch control of influenza vaccines: Is it still useful?Vaccine2018362364237010.1016/j.vaccine.2018.02.07829580639Search in Google Scholar
Liesegang T.J.: Varicella zoster virus vaccines: effective, but concerns linger. Canadian J Ophthalmol 2009, 44, 379–384. doi:10.3129/i09-126. PMID 19606157.LiesegangT.J.Varicella zoster virus vaccines: effective, but concerns lingerCanadian J Ophthalmol200944379384doi10.3129/i09-126PMID 1960615719606157Open DOISearch in Google Scholar
Markey K., Douglas-Bardsley A., Hockley J., Le Tallec D., Costanzo A.: Calibration of pertussis toxin BRP batch 1 in a standardised CHO cell-based clustering assay. Pharmeur Bio Sci Notes 2018, 112–123.MarkeyK.Douglas-BardsleyA.HockleyJ.Le TallecD.CostanzoA.Calibration of pertussis toxin BRP batch 1 in a standardised CHO cell-based clustering assayPharmeur Bio Sci Notes2018112123Search in Google Scholar
Matejtschuk P., Duru C., Bristow A.F., Burns C.J., Cowper B., Daas A., Costanzo A.: Establishment of detection antibodies BRRs batch 5 for in vitro potency assay of hepatitis A vaccines by ELISA. Pharmeur Bio Sci Notes 2019, 11–26.MatejtschukP.DuruC.BristowA.F.BurnsC.J.CowperB.DaasA.CostanzoA.Establishment of detection antibodies BRRs batch 5 for in vitro potency assay of hepatitis A vaccines by ELISAPharmeur Bio Sci Notes20191126Search in Google Scholar
Medycyna Praktyczna: Klasyfikacja i skład szczepionek (Classification and composition of vaccines (in Polish)). https://www.mp.pl/pacjent/choroby-zakazne/szczepienia/158371,klasyfikacja-i-sklad-szczepionekMedycyna Praktyczna: Klasyfikacja i skład szczepionek (Classification and composition of vaccines (in Polish))https://www.mp.pl/pacjent/choroby-zakazne/szczepienia/158371,klasyfikacja-i-sklad-szczepionekSearch in Google Scholar
Morgeaux S., Koy A., Manniam I., Regourd E., Variot P., Milne C.: Establishment of detection antibodies BRRs batch 5 for in vitro potency assay of hepatitis A vaccines by ELISA. Pharmeur Bio Sci Notes 2019, 1–10.MorgeauxS.KoyA.ManniamI.RegourdE.VariotP.MilneC.Establishment of detection antibodies BRRs batch 5 for in vitro potency assay of hepatitis A vaccines by ELISAPharmeur Bio Sci Notes2019110Search in Google Scholar
Sass J., Becker K., Ludmann D., Pantazoglou E., Dewenter H., Thun S.: Intercoder reliability of mapping between pharmaceutical dose forms in the German Medication Plan and EDQM Standard Terms. Stud Health Technol Inform 2018, 247, 845–849.SassJ.BeckerK.LudmannD.PantazoglouE.DewenterH.ThunS.Intercoder reliability of mapping between pharmaceutical dose forms in the German Medication Plan and EDQM Standard TermsStud Health Technol Inform2018247845849Search in Google Scholar
United States Centers for Disease Control and Prevention: A CDC framework for preventing infectious diseases: Sustaining the Essentials and Innovating for the Future. https://www.cdc.gov/ddid/framework.htmlUnited States Centers for Disease Control and Prevention: A CDC framework for preventing infectious diseases: Sustaining the Essentials and Innovating for the Futurehttps://www.cdc.gov/ddid/framework.htmlSearch in Google Scholar
United States Department of Health and Human Services: Types of vaccines. https://www.vaccines.gov/basics/types/index.htmlUnited States Department of Health and Human Services: Types of vaccineshttps://www.vaccines.gov/basics/types/index.htmlSearch in Google Scholar
Wanko R., Unkelbach U.: European network of official medicines control laboratories: international OMCL Working Group combating counterfeit and other illegal medicines. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2017, 60, 1221–1227. doi: 10.1007/s00103-017-2625-7.WankoR.UnkelbachU.European network of official medicines control laboratories: international OMCL Working Group combating counterfeit and other illegal medicinesBundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz20176012211227doi10.1007/s00103-017-2625-728921172Open DOISearch in Google Scholar